secwatch / observer
8-K filed February 2, 2024, 6:59 PM ET ticker IMRX CIK 0001790340
other confidence high sentiment neutral materiality 0.10

Immuneering amends bylaws to address universal proxy rules and enhance stockholder meeting procedures

Immuneering Corp

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Immuneering Corp: Amended and restated bylaws to address universal proxy rules, enhance stockholder nomination and proposal procedures, and require white proxy card for stockholder solicitations (effective 2024-02-01).

Change
bylaw amendment
Effective
2024-02-01
Exact text from the filing
On February 1, 2024, the Board of Directors (the “Board”) of Immuneering Corporation (the “Company”) adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.
View on SEC.gov

259 governance changes filed in the last 30 days. Browse all governance changes →

Immuneering Corp filing history →

Source: SEC EDGAR
accession 0001104659-24-010041
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.